We are live on ! Find out more
Parallel Advisors

Parallel Advisors Portfolio holdings

AUM $6.56B Turnover 11.49%
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
+8.88%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$5B
AUM Growth
+$569M
Cap. Flow
+$104M
Cap. Flow %
2.08%
Top 10 Hldgs %
38.84%
Holding
3,762
New
251
Increased
1,450
Reduced
1,277
Closed
224
Avg Time Held Equity + Options
4.7 years
Top 10 Avg Time Held Equity + Options
2.9 years
Top 20 Avg Time Held Equity + Options
3.8 years
Avg Time Held Equity only
4.7 years
Top 10 Avg Time Held Equity only
2.9 years
Top 20 Avg Time Held Equity only
3.8 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 46.71%
2 Technology 17.21%
3 Healthcare 9.68%
4 Financials 7.2%
5 Communication Services 5.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
GEF.B icon
3326
Greif Class B
GEF.B
$4.14B
$345 ﹤0.01%
+5
New +$303
2025 Q2
0 quarters
TDUP icon
3327
ThredUp
TDUP
$311M
$345 ﹤0.01%
46
– –
2023 Q1
9 quarters
SLVP icon
3328
iShares MSCI Global Silver and Metals Miners ETF
SLVP
$835M
$338 ﹤0.01%
19
– –
2022 Q1
13 quarters
MHO icon
3329
M/I Homes
MHO
$3.22B
$336 ﹤0.01%
3
-11
-79% -$1.2K
2024 Q1
5 quarters
KLG icon
3330
DELISTED
WK Kellogg Co
KLG
$335 ﹤0.01%
21
-31
-60% -$539
2023 Q4
6 quarters
OSPN icon
3331
OneSpan
OSPN
$654M
$334 ﹤0.01%
+20
New +$310
2025 Q2
0 quarters
NRDY icon
3332
Nerdy
NRDY
$51.6M
$332 ﹤0.01%
+14
New +$335
2025 Q2
0 quarters
STRO icon
3333
Sutro Biopharma
STRO
$191M
$332 ﹤0.01%
47
– –
2021 Q1
17 quarters
XPER icon
3334
Xperi
XPER
$246M
$332 ﹤0.01%
+42
New +$317
2025 Q2
0 quarters
CWCO icon
3335
Consolidated Water Co
CWCO
$475M
$330 ﹤0.01%
+11
New +$285
2025 Q2
0 quarters
SHBI icon
3336
Shore Bancshares
SHBI
$757M
$330 ﹤0.01%
+21
New +$295
2025 Q2
0 quarters
FCF icon
3337
First Commonwealth Financial
FCF
$2.04B
$325 ﹤0.01%
+20
New +$308
2025 Q2
0 quarters
EPOL icon
3338
iShares MSCI Poland ETF
EPOL
$843M
$323 ﹤0.01%
10
– –
2023 Q2
8 quarters
REAX icon
3339
Real REMAX Group Inc. Common Stock
REAX
$327M
$320 ﹤0.01%
7
-35
-83% -$1.51K
2025 Q1
1 quarter
VERX icon
3340
Vertex
VERX
$2.14B
$318 ﹤0.01%
+9
New +$342
2025 Q2
0 quarters
SNCY icon
3341
DELISTED
Sun Country Airlines
SNCY
$317 ﹤0.01%
27
-30
-53% -$330
2025 Q1
1 quarter
NGVC icon
3342
Vitamin Cottage Natural Grocers
NGVC
$726M
$314 ﹤0.01%
8
– –
2024 Q3
3 quarters
WB icon
3343
Weibo
WB
$1.62B
$314 ﹤0.01%
33
-473
-93% -$4.16K
2019 Q3
23 quarters
IRBT icon
3344
DELISTED
iRobot
IRBT
$313 ﹤0.01%
+100
New +$277
2025 Q2
0 quarters
HLF icon
3345
Herbalife
HLF
$1.52B
$310 ﹤0.01%
36
– –
2025 Q1
1 quarter
KRT icon
3346
Karat Packaging
KRT
$1.08B
$310 ﹤0.01%
11
-16
-59% -$446
2024 Q3
3 quarters
DFIN icon
3347
Donnelley Financial Solutions
DFIN
$1.24B
$308 ﹤0.01%
5
-30
-86% -$1.55K
2022 Q1
13 quarters
SMBS icon
3348
Schwab Mortgage-Backed Securities ETF
SMBS
$6.19B
$306 ﹤0.01%
+12
New +$302
2025 Q2
0 quarters
MLYS icon
3349
Mineralys Therapeutics
MLYS
$1.9B
$298 ﹤0.01%
22
– –
2023 Q4
6 quarters
KEEL icon
3350
Keel Infrastructure Corp
KEEL
$1.49B
$294 ﹤0.01%
350
– –
2023 Q4
6 quarters

Similar funds

Parallel Advisors's Q2 2025 Portfolio in Review

As of Q2 2025, Parallel Advisors held 3,762 positions worth $5B, up 13% from $4.43B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Parallel Advisors's Q2 2025 filing shows 251 new, 1,450 increased, 1,277 reduced and 224 closed positions. Its largest new stake was Vanguard 0-3 Month Treasury Bill ETF: 32,722 shares worth $2.47M. The largest sale was Corcept Therapeutics, an estimated $7.34M.

By sector, the portfolio is most concentrated in Miscellaneous at 47% of assets, down from 47% a quarter earlier, followed by Technology and Healthcare.

  • Parallel Advisors's largest Q2 2025 buy was Vanguard 0-3 Month Treasury Bill ETF: 32,722 shares worth $2.47M.
  • Parallel Advisors added most to iShares Core S&P 500 ETF in Q2 2025, an estimated $18.4M increase.
  • Parallel Advisors's biggest Q2 2025 reduction was Corcept Therapeutics, cutting an estimated $7.34M.
  • Parallel Advisors fully exited Discover Financial Services in Q2 2025, selling an estimated $1.22M.
  • Parallel Advisors's ten largest holdings make up 39% of its $5B portfolio in Q2 2025.
  • Parallel Advisors opened 251 new positions and closed 224 in Q2 2025.
  • Parallel Advisors's portfolio value rose 13% quarter-over-quarter to $5B.

Based on Parallel Advisors's 13F filing for Q2 2025, filed 8 Jul 2025.